Prevalence, Characteristics, and Outcomes of Infective Endocarditis Readmissions in Patients With Variables Associated With Liver Disease in the United States

• Published in: Angiology p. 33197241227502
• Main Authors: Khayata, Mohamed, Grimm, Richard A, Griffin, Brian P, Xu, Bo
• Format: Journal Article
• Language: English
• Published: United States 12-01-2024
• Subjects: infective endocarditis; liver disease; outcomes; readmission
• ISSN: 0003-3197; 1940-1574
• DOI: 10.1177/00033197241227502

Infective endocarditis (IE) is common in patients with liver disease. Outcomes of IE in patients with liver disease are limited. We aimed to investigate IE outcomes in patients with variables associated with liver disease in the USA. We used the 2017 National Readmission Database to identify index admission of adults with IE, based on the International Classification of Disease, 10
revision codes. The primary outcome was 30-day readmission. Secondary outcomes were mortality and predictors of hospital readmission. We identified 40,413 IE admissions. Patients who were readmitted were more likely to have a history of HCV (19.4 vs 12.3%,
< .001), hyponatremia (25 vs 21%,
< .001), and thrombocytopenia (20.3 vs 16.3%,
< .001). After adjusting for age, hypertension, heart failure, diabetes mellitus, and end stage renal disease, hyponatremia (odds ratio (OR) 1.25; 95% confidence intervals [CI]: 1.17-1.35;
< .001) and thrombocytopenia (OR 1.16; 95% CI: 1.08-1.24;
< .001) correlated with higher odds of 30-day readmission. Mortality was higher among patients with hyponatremia (29 vs 22%,
< .001), thrombocytopenia (29 vs 17%,
< .001), coagulopathy (12 vs 5%,
< .001), cirrhosis (6 vs 4%,
< .001), ascites (7 vs 3%,
< .001), liver failure (18 vs 3%,
< .001), and portal hypertension (3 vs 1.5%,
< .001).